1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RP11-293I14.2 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA BCAP31 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA FLRT3 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA PLOD3 CTRPv2 pan-cancer AAC 0.16 0.0002
mRNA CFL2 CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA ARID3A CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA MTHFD2 CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA SYNC CTRPv2 pan-cancer AAC -0.16 0.0002
mRNA LINGO3 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA TLR8 CTRPv2 pan-cancer AAC 0.13 0.0003
Download CSV